ORZA
C/Hondarribia, nº 31, 1º Derecha, Donostia-San Sebastián, Gipuzkoa, 20005, Spain
Overview
ORZA is a direct investment entity, part of the ELKARKIDETZA and GEROA pension funds, which deals with the acquisition of shares in businesses. It supports the Basque business sector through expansion and internationalisation projects, MBO and MBI transactions, to resolve questions of corporate succession and in the substitution of minority shareholders.
- Total investments
- 12
- Lead investments
- 2
- Investments · 12mo
- 1
- Active investors
- 1
Sector focus
- Asset Management
- Finance
Investment portfolio
- Revenant
Participated · Equity · Jul 2026
Revenant is an industrial small-to-medium enterprise committed to the circular economy that designs and manufactures large-tonnage forklifts and port/industrial tow tractors. The company plans to relocate production to a new plant to significantly increase capacity while maintaining its current Gordexola facilities as an R&D and new-model development hub. Recent financing of €3.3 million will fund the start-up of the new production site and support the addition of advanced functionalities and technologies to its machinery. Revenant emphasizes continued investment in innovation to offer more efficient and sustainable solutions to customers. Management, led by CEO Alex López, positions the company to industrialize its value proposition and scale in its target markets. No historical revenue or user metrics were disclosed in the article.
- Mikrobiomik
Led · Equity · Sep 2023
Mikrobiomik develops MBK-01, a biologic therapy based on its FSPIM® (Full Spectrum & Purified Intestinal Microbiota) delivered as lyophilized oral capsules to treat primary and recurrent Clostridioides difficile infections. The company is completing the phase III ICD-01 trial comparing MBK-01 to fidaxomicin; preliminary results are described as encouraging and final data were expected by the end of 2023. Mikrobiomik has supplied MBK-01 free to more than 25 patients via a compassionate-use program. The company plans to submit the regulatory dossier for MBK-01 to the European Medicines Agency via the centralized procedure and aims for a European market launch in the first half of 2025. Since its 2018 founding, it has been supported by investors including Orza and Seed Capital Bizkaia and has raised additional capital to advance development.
- Deneb Medical
Participated · Equity · Apr 2022
Deneb Medical, S.L. develops a robotic surgical platform designed for spine surgeries. The platform aims to provide spine surgeons with predictable, optimal surgical outcomes while helping hospitals reduce surgical costs. The company reached an investment agreement with CDTI (via its Innvierte program), Orza Gestión and Tenencia de Patrimonios, AIE. CDTI committed €250,000 as part of the investment. Orza Gestión is presented as a direct investment entity that supports Basque and Navarre companies and can finance successive growth phases. The involvement of CDTI’s Innvierte initiative indicates the funding is intended to support Deneb’s capitalization and further development.
- SATLANTIS
Participated · Equity · Nov 2021
SATLANTIS builds multispectral infrared satellite technology to capture and measure greenhouse gas emissions, notably high-precision methane detection. The company is developing a GEI-SAT satellite for Enagás and offers satellite-based monitoring services via microsatellite systems. SATLANTIS has completed six space missions and claims world-leading optical space observation technology. A US subsidiary exists to support growth in the North American market and the company plans to develop new products and services for that market. The latest financing round brought new international investment to accelerate emissions-monitoring services and support the energy transition. Sean O'Keefe was appointed President of SATLANTIS LLC as part of the company’s U.S. leadership and partnership effort. Satlantis develops extreme miniaturisation camera technology and environmental satellites for Earth observation, with projects endorsed by Copernicus and the European Space Agency. The company led the OPTISSE project for European Defence, heading a six‑company consortium and demonstrating feasibility of 50cm resolution with its miniaturised cameras. It is building a new environmental satellite covering the visible, shortwave and mid‑wave infrared spectrum to detect methane emissions. That methane‑detection satellite is scheduled for launch in June 2023 and aligns with upcoming European regulation on methane for the Oil & Gas sector. Satlantis plans to use recent financing to pursue internationalisation to the US, the UK, Central Asia and the United Arab Emirates and to shorten industry lead times by offering satellite solutions in months rather than years. The company also received a rating of excellence from the European Commission, which awarded a follow‑on project to focus OPTISSE results on maritime monitoring. Satlantis develops satellite sensors and solutions focused on environmental monitoring, including methane detection, marine plastic identification and fire detection. The company says its methane measurement capability reaches very high precision (5 meters), a resolution it describes as previously unattained. Leadership includes Jean‑Jacques Dordain, former director general of the European Space Agency. Satlantis employs about 45 engineers and positions itself to serve customers across the value chain, including Copernicus, ESA missions and the oil & gas sector. With the new funding the company plans to launch SATLANTIS International to develop activity in the USA, UK and the United Arab Emirates. Satlantis develops high-resolution imaging cameras that integrate into nanosatellites to capture real-time images of the Earth’s surface. The company was founded in 2014 and counts former minister Cristina Garmendia among its founders. Satlantis is focused on qualifying its cameras for space launch and standardizing devices to enable series manufacturing. It operates in the industrial automation/robotics sector with R&D and manufacturing plans centered in Bilbao, Basque Country. In March 2016 the company closed a €2.35M venture-capital round intended to support product development and a new factory in Bilbao. The round involved strategic and institutional investors collaborating to back the company’s next development phase.
- CounterCraft
Participated · Equity · Jun 2020
CounterCraft's Threat Deception Platform deceives cyberattackers into decoy architectures and records detailed data about how, what, when and where attackers attempted to penetrate a client's systems. The platform harvests intelligence from assets such as WiFi, SWIFT, email accounts and social media and can automatically convert that harvested data into proactive responses. The company describes its approach as “proactive defense” and adopts a Know‑Your‑Attacker stance to improve the quality of intelligence gathered. CounterCraft serves clients across Western Europe and North America, particularly national defense and intelligence departments, financial institutions and large enterprises. Founded in 2015 and headquartered in San Sebastian with offices in Madrid and London, the startup plans to expand its presence with sophisticated, large clients in the U.S. and European markets. Financially, CounterCraft recently raised $5 million in a funding round led by Adara Ventures. Countercraft develops online counterintelligence tools for the cybersecurity market, offering three types of licenses based on the number of campaigns customers run. The company was accelerated in Wayra UK and Wayra Madrid invested in the business. Its client base includes more than 20 Fortune 500 companies. Countercraft has about 20 employees and was founded two years before the article by three partners, including David Barroso and Fernando Braquehais. The startup has raised funds to develop its technology and expects first-year revenue of €1 million, with a 2018 revenue target of €3–4 million. It plans to use new capital to expand internationally across Europe, the Middle East and the United States. Countercraft develops automated online counterintelligence tools that create credible lures and false information to manipulate and monitor attackers. Its platform is sold via three types of licenses depending on the number of campaigns a customer wants to run. The company was founded two years earlier by three security specialists including David Barroso and Fernando Braquehais. Customers include more than 20 Fortune500 companies, and for its first fiscal year Countercraft expected to generate €1 million in revenue. The company planned to expand into new European countries and the Middle East in 2018 with a revenue target of €3–4 million. Countercraft operates from offices in London and Madrid. CounterCraft develops deception‑based counter‑intelligence cybersecurity solutions that use techniques and tools to detect, discover and manipulate attackers. The company runs counterintelligence campaigns aimed at detecting and neutralizing espionage and cybercrime operations. Founded in September 2015 by David Barroso (CEO), Dan Brett (CMO) and Fernando Braquehais (Software Architect), it was winner of the INCIBE acceleration program. CounterCraft has previously received financing from CDTI (via the Ministry of Economy and Competitiveness) and from BicGipuzkoa through SPRI. In July 2016 the company closed a €1 million venture capital round to accelerate product development and support international expansion.
Team
aitor arrizabalaga kaltzakorta
Founder & Managing Director
LinkedIn